Health Care/Hospital News & Press Release Distribution

Origin Agritech Comments on Recent Regulatory Developments in China and Updates Shareholders on its Pipeline of Traits

BEIJING, Dec. 22, 2020 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), an agriculture technology company, today is updating shareholders on recent developments out ofChina regarding the path to GMO commercialization in the country and also on the status of the app...

2020-12-22 20:30 5177

Overweight and Obese Subjects Dosed with ASC41 Tablets in a Phase Ib Trial

SHANGHAI, Dec. 22, 2020 /PRNewswire/ -- Gannex, a wholly owned company of Ascletis Pharma Inc. (HKEX: 1672) and fully dedicated to the R&D and commercialization of new drugs in the field of NASH, announces today dosing of overweight and obese subjects in a Phase Ib trial of ASC41, an oral tablet,...

2020-12-22 19:18 2753

Ascentage Pharma's Licensee UNITY Biotechnology Announces Milestone Reached in Clinical Development of Treatments for Age-Related Disease, Leading to Milestone Payment

SUZHOU, China and ROCKVILLE, Md., Dec. 22, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that its licensee, UNITY Bi...

2020-12-22 18:29 1650

111, Inc. Announces Additional Round of New Capital Injection

SHANGHAI, Dec. 22, 2020 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading digital healthcare platform company committed to digitally connecting patients with medicine and healthcare services inChina, today announced the successful completion of new capital injection in it...

2020-12-22 17:22 11699

Leapstack has completed tens of millions of yuan in B plus round fundraising, expending intelligent risk control territory

SHANGHAI, Dec. 22, 2020 /PRNewswire/ -- Leapstack, an insur-tech company, has recently announcedtens of millions of yuan B plus round fundraising, leading by Huazhi Capital, a venture capitalist affiliated toAllinpay Network Services, and following by GF Securities Investment. In the past few ye...

2020-12-22 15:50 4378

Alterity and UniQuest partner to reverse bacterial resistance to antibiotics

MELBOURNE, Australia, Dec. 21, 2020 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company") has today announced it has been granted a licence by UniQuest, the commercialisation company of The University of Queensland (UQ), to novel zinc ionophore technology to ...

2020-12-22 05:42 5530

Home is Where the Heart is for Students, GSA Reveals

Global poll reveals what students really crave this Christmas MELBOURNE, Australia, Dec. 22, 2020 /PRNewswire/ -- 2020 is set to be a festive season like no other, but new research* released today has shown that some things never change, as all students really want is a roast dinner and quality...

2020-12-22 05:00 2434

Home is Where the Heart is for Students, GSA Reveals

DW Healthcare Partners V, L.P. Announces Commencement of the Tender Offer for All Outstanding Ordinary Shares of Parnell Pharmaceuticals Holdings Ltd

PARK CITY, Utah, Dec. 22, 2020 /PRNewswire/ -- DW Healthcare Partners V, L.P. ("Purchaser"), announced today that it has commenced a cash tender offer for all of the outstanding ordinary shares of Parnell Pharmaceuticals Holdings Ltd (OTC Pink Open Market: PARNF) ("Parnell") at a price of U.S.$0....

2020-12-21 23:07 13729

Pierre Fabre Selects AGC Biologics as CDMO to manufacture the orphan drug ER-004

SEATTLE, Dec. 21, 2020 /PRNewswire/ -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced its partnership with Laboratoire Pierre Fabre to manufacture ER-004 – an intra-amniotic drug that will pioneer the treatment of a rare and...

2020-12-21 23:00 1430

Pierre Fabre Selects AGC Biologics as CDMO to manufacture the orphan drug ER-004

SEATTLE, Dec. 21, 2020 /PRNewswire/ -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced its partnership with Laboratoire Pierre Fabre to manufacture ER-004 – an intra-amniotic drug that will pioneer the treatment of a rare and...

2020-12-21 23:00 2587

Servier to Acquire Agios Pharmaceuticals' Oncology Business

- Transaction includes commercial, clinical and research-stage oncology portfolio and employees for up to$2 billion plus royalties - Includes Agios' marketed medicine TIBSOVO® and a strong oncology pipeline of Phase 3 and early-stage assets - Acquisition in-line with Servier's strategic ambition...

2020-12-21 22:26 1693

Honeywell And Signify Team Up To Deploy Integrated Lighting Solutions To Improve Occupant Experience

- Honeywell adds Signify's lighting systems and software to its Healthy Buildings solutions to improve occupant experience, productivity and well-being - Includes Signify's UV-C disinfection lighting, connected lighting, human-centric lighting and occupancy, space and environmental monitoring - ...

2020-12-21 22:19 6262

Major Breakthrough: DragonFly-T™ First Transcatheter Tricuspid Valve Repair Surgery in China

HANGZHOU, China, Dec. 21, 2020 /PRNewswire/ -- On December 15, 2020, Professor Wang Jian'an's team from the Second Hospital of Zhejiang University School of Medicine successfully applied the DragonFly-T™ Transcatheter Tricuspid Valve Clamping System to perform the first human clinical application...

2020-12-21 22:18 1507

LT1001 (Naldebain(R)), an Extended-Release Analgesic Injection, Received Its Second Approval from Singapore's HSA

TAIPEI, Dec. 21, 2020 /PRNewswire/ -- Lumosa Therapeutics is pleased to announce the market approval of LT1001 (Naldebain®), an extended-release analgesic injection, fromSingapore's Health Science Agency (HSA). HSA is regarded as one of the regulatory reference countries in the world. The approv...

2020-12-21 22:08 1709

WuXi Biologics to Acquire Drug Substance Facility in Wuppertal, Germany from Bayer

* The DS facility (MFG19) with 3x1000L perfusion and 6x2000L fed-batch capacity for vaccines and biologics is expected to be GMP ready in late 2021 * Complements WuXi Biologics' existing DP capacity in Germany * Capacity expansion allows WuXi Biologics to meet growing client demand worldwide...

2020-12-21 21:02 1868

Longevity Acquisition Corporation Announces 4D pharma Joining Landmark Parkinson's Progression Markers Initiative

NEW YORK, Dec. 21, 2020 /PRNewswire/ -- Longevity Acquisition Corporation (NASDAQ: LOAC) (the "Company"), a publicly-traded special purpose acquisition company, announced today that onDecember 18, 2020, 4D pharma plc (AIM: DDDD) ("4D pharma"), a pharmaceutical company leading the development of L...

2020-12-21 21:00 10698

BioVaxys Vaccine Platform Stimulates Robust T-cell Response Against Viral Antigens

VANCOUVER, British Columbia, Dec. 21, 2020 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV, FRA:5LB, OTC:LMNGF) ("BioVaxys") announced today that further analysis of the data from a preclinical animal study (also known as the "murine model study") of its haptenized viral protein vaccine tech...

2020-12-21 21:00 2016

Neusoft Medical has reached a strategic cooperation of Sino-Pakistan Healthcare in Pakistan

SHENYANG, China, Dec. 21, 2020 /PRNewswire/ -- Neusoft Medical Systems Co., Ltd. (Neusoft Medical) announced the cloud signing of a memorandum of understanding (MOU) with Dynamic Engineering and Automation Group (DEA) to cooperate in the area of healthcare inPakistan. The partnership intends to ...

2020-12-21 19:18 1472

Neusoft Medical has reached a strategic cooperation of Sino-Pakistan Healthcare in Pakistan

Sifi Launches Well Fusion, A Novel Presbyopia Correcting System

- Spectacle-free uninterrupted high-quality vision for cataract patients CATANIA, Italy, Dec. 21, 2020 /PRNewswire/ -- SIFI, a leading international eye care company, today announces the launch of theWELL FUSION™ system and the Mini WELL PROXA®intraocular lens, offering a novel solution that prov...

2020-12-21 19:00 2465

Medit announces Straumann Group as a distributor for its intraoral scanners

SEOUL, South Korea, Dec. 21, 2020 /PRNewswire/ -- Medit and Straumann have entered a global distribution partnership for intraoral scanners effective as of January 1st, 2021. This agreement leverages the existing partnership of the two companies for dental lab scanners. The distribution agreeme...

2020-12-21 14:00 2666